An observational study in Cancer, sponsored by El Zaitoun Specialized Hospital. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-28.
Sponsored by El Zaitoun Specialized Hospital · Observational
The situation of COVID-19 pandemic creates many challenges for cancer patients and caregivers. Some modifications in cancer management have been evolved from cancer societies and organizations to support oncology professionals as much as possible to deliver optimal care to their cancer patients in such exceptional circumstances, and to protect patients from infection with COVID-19 as much as possible.
In oncology practice during this pandemic, many cancer patients still feeling uncertainty about their cancer management and treatment outcome . The study is aiming to better understand the impact of the COVID-19 pandemic on cancer care from patients' and survivors' perspective.
7,641 studies on the registry are indexed under COVID-19; 487 are open to participants now.
This study's enrollment of 300 is above the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →This is the only study on the registry with El Zaitoun Specialized Hospital as lead sponsor.
Counted across the registry records on this site, refreshed daily.
the study survey will be distributed through social media to cancer patients and survivors in Egypt. We plan to enroll as many participants as possible without limitation of the number although we hope to achieve at least 400 participants.
Exclusion Criteria:
online survey
patients' and survivors' perspective of their cancer care during COVID-19 pandemic
measured by online survey to understand the impact of COVID-19 pandemic on cancer care
Time frame: one month
Plan to share: Undecided — email
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.